+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Minoxidil Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

  • ID: 5328027
  • Report
  • January 2021
  • Region: Global
  • Coherent Market Insights Pvt Ltd.

FEATURED COMPANIES

  • Actavis Pharma, Inc.
  • AmWiner & Raphe Holdings
  • Apotex Corporation
  • ATOM PHARMA
  • DS LABORATORIES, INC.
  • LGM Pharma
Minoxidil is an antihypertensive available in topical as well as oral solution used for hair loss treatment. It helps to stimulate hair growth and to slow balding. This drug is U.S. Food & Drug Administration (U.S. FDA) approved for androgenetic alopecia and female pattern hair loss. Moreover, it is also available off label for alopecia areata, beard enhancement, and central centrifugal cicatricial alopecia.

Market Dynamics

Rising incidence of androgenetic alopecia is expected to drive the global minoxidil market growth. According to the National Library of Medicine (NLM), a medical library which is part of the National Institutes of Health (NIH), androgenetic alopecia affects approximately 50 million men and 30 million women in the U.S.

However, side effects of minoxidil is expected to hinder the market growth. For instance, according to the National Center for Biotechnology Information (NCBI), August 2019, topical minoxidil show some side effects such as irritant contact dermatitis with the typical symptoms of itching and scaling.

Key features of the study:
  • This report provides in-depth analysis of the global minoxidil market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020–2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global minoxidil market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Pfizer Inc., ATOM PHARMA, LGM Pharma, Perrigo Company plc, AmWiner & Raphe Holdings, Johnson and Johnson Services, Inc., Sigma Aldrich (Merck KGaA), Actavis Pharma, Inc., Remedy Repack, Apotex Corporation, TRILOGIC LTD, DS LABORATORIES, INC., Incredible Products, S.A. de C.V., and Taisho Pharmaceutical Co., Ltd among others
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, drug class up-gradation, market expansion, and marketing tactics
  • The global minoxidil market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global minoxidil market
Detailed Segmentation:

Global Minoxidil Market, By Type:
  • 5% Minoxidil
  • 2% Minoxidil
Global Minoxidil Market, By Route of Administration:
  • Oral
  • Topical
Global Minoxidil Market, By Gender:
  • Male
  • Female
Global Minoxidil Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Global Minoxidil Market, By Region:
  • North America
  • By Country
  • U.S.
  • Canada
  • Latin America
  • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Country/Region
  • South Africa
  • Central Africa
  • North Africa
Company Profiles
  • Pfizer Inc.*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Highlights
  • Market Strategies
  • ATOM PHARMA
  • LGM Pharma
  • Perrigo Company plc
  • AmWiner & Raphe Holdings
  • Johnson and Johnson Services, Inc.
  • Sigma Aldrich (Merck KGaA)
  • Actavis Pharma, Inc.
  • Remedy Repack
  • Apotex Corporation
  • TRILOGIC LTD
  • DS LABORATORIES, INC.
  • Incredible Products, S.A. de C.V.
  • Taisho Pharmaceutical Co., Ltd
“*” marked represents similar segmentation in other categories in the respective section.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Actavis Pharma, Inc.
  • AmWiner & Raphe Holdings
  • Apotex Corporation
  • ATOM PHARMA
  • DS LABORATORIES, INC.
  • LGM Pharma
1. Research Objectives and Assumptions
  • Research Objectives
  • Assumptions
  • Abbreviations
2. Market Purview
  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snippet, By Type
  • Market Snippet, By Gender
  • Market Snippet, By Route of Administration
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Region
  • Opportunity Map
3. Market Dynamics, Regulations, and Trends Analysis
  • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
  • Impact Analysis
  • Pipeline Analysis
  • Reimbursement Scenario
  • Epidemiology
  • Pest Analysis
  • Regulatory Scenario
  • New Product Launches
  • Collaborations and Agreements
  • Market Trends
4. Global Minoxidil Market - Impact of Coronavirus (COVID-19) Pandemic
  • COVID-19 Market Scenario
  • Impact of COVID-19 Market on the Minoxidil Products
5. Global Minoxidil Market, By Type, 2016-2027, (US$ Mn)
  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017 - 2027
  • Segment Trends
  • 5% Minoxidil
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
  • 2% Minoxidil
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
6. Global Minoxidil Market, By Gender, 2016-2027, (US$ Mn)
  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017 - 2027
  • Segment Trends
  • Male
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
  • Female
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
7. Global Minoxidil Market, By Route of Administration, 2016-2027, (US$ Mn)
  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017 - 2027
  • Segment Trends
  • Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
  • Topical
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
8. Global Minoxidil Market, By Distribution Channel, 2016-2027, (US$ Mn)
  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017 - 2027
  • Segment Trends
  • Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
  • Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
  • Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
9. Global Minoxidil Market, By Region, 2016-2027, (US$ Mn)
  • Introduction
  • Market Share Analysis, By Region, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017-2027
  • North America
  • Market Size and Forecast, By Type, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Gender, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Country, 2016-2027, (US$ Mn)
  • U.S.
  • Canada
  • Latin America
  • Market Size and Forecast, By Type, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Gender, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Country, 2016-2027, (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • Market Size and Forecast, By Type, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Gender, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Country, 2016-2027, (US$ Mn)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Market Size and Forecast, By Type, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Gender, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Country, 2016-2027, (US$ Mn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • Market Size and Forecast, By Type, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Gender, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Country, 2016-2027, (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • Market Size and Forecast, By Type, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Gender, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027, (US$ Mn)
  • Market Size and Forecast, By Country/Region, 2016-2027, (US$ Mn)
  • South Africa
  • Central Africa
  • North Africa
10. Competitive Landscape
  • Heat Map Analysis
  • Market Share Analysis
  • Pfizer Inc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • ATOM PHARMA
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • LGM Pharma
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Perrigo Company plc
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • AmWiner & Raphe Holdings
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Johnson and Johnson Services, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Sigma Aldrich (Merck KGaA)
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Actavis Pharma, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Remedy Repack
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Apotex Corporation
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • TRILOGIC LTD
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • DS LABORATORIES, INC.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Incredible Products, S.A. de C.V.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Taisho Pharmaceutical Co., Ltd
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Analyst Views
11. Section
  • References
  • Research Methodology
  • About us and Sales Contact
Note: Product cover images may vary from those shown
  • Pfizer Inc.
  • ATOM PHARMA
  • LGM Pharma
  • Perrigo Company plc
  • AmWiner & Raphe Holdings
  • Johnson and Johnson Services, Inc.
  • Sigma Aldrich (Merck KGaA)
  • Actavis Pharma, Inc.
  • Remedy Repack
  • Apotex Corporation
  • TRILOGIC LTD
  • DS LABORATORIES, INC.
  • Incredible Products, S.A. de C.V.
  • Taisho Pharmaceutical Co., Ltd
Note: Product cover images may vary from those shown
Adroll
adroll